|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.76 CNY | -0.08% |
|
-10.36% | -24.55% |
| Apr. 29 | China, HK stocks rise, led by property shares | RE |
| Apr. 26 | Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Hangzhou Alltest Biotech Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 3,010.07 million compared to CNY 996.86 million a year ago. Revenue was CNY 3,010.07 million compared to CNY 996.86 million a year ago.
Net income was CNY 1,360.55 million compared to CNY 482.32 million a year ago. Basic earnings per share from continuing operations was CNY 17.0541 compared to CNY 6.4662 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.55% | 554M | |
| -6.76% | 11.98B | |
| -5.68% | 8B | |
| +8.91% | 5.85B | |
| +28.87% | 5.54B | |
| -15.84% | 3.84B | |
| +10.70% | 2.66B | |
| -60.92% | 2.62B | |
| -6.99% | 2.33B | |
| +15.67% | 2B |
HANGZHOU ALLTEST BIOTECH CO., LTD. 
